Buckingham Strategic Partners Geron Corp Transaction History
Buckingham Strategic Partners
- $6.15 Billion
- Q1 2025
A detailed history of Buckingham Strategic Partners transactions in Geron Corp stock. As of the latest transaction made, Buckingham Strategic Partners holds 24,370 shares of GERN stock, worth $35,336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,370Holding current value
$35,336% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GERN
# of Institutions
295Shares Held
496MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$87.6 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$67.5 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$55.4 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$49.5 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$39.5 Million11.75% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $548M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...